With scientists studying if new semaglutide weight loss drugs could potentially treat dementia, many have questions about the potential impact of Ozempic and Wegovy…
Some early studies suggested a class of diabetes drugs called GLP-1 agonists, which have been proven to also help people lose weight and reduce…
A new anti-amyloid drug for Alzheimer’s disease might receive FDA approval as soon as this month. Although anti-amyloid drugs have shown us that clear…
Prescription drugs and vaccines revolutionized health care, dramatically decreasing death from disease and improving quality of life across the globe. But how do researchers,…
A recent study reported that sildenafil, sold under the brand name Viagra, and other medicines from the same group called phosphodiesterase type-5 inhibitors may…
Believe it or not, Pfizer’s drug Viagra was originally designed to treat cardiovascular problems. Early on in clinical trials, men taking the drug became…
At least one in four people with Alzheimer’s experience apathy. Despite its prevalence, existing drugs for Alzheimer’s cognitive symptoms don’t address this symptom. But…
Dozens of drugs designed to target and clear beta-amyloid plaques in the brain have failed to prevent or halt the progression of Alzheimer’s disease….
Almost 60 percent of people with Alzheimer’s also show signs of seizure-like brain activity. In total, more than one fifth of people with Alzheimer’s…
Analyzing large databases of human data, scientists identified a “water pill” called bumetanide, which reduced the risk of developing Alzheimer’s for people with a…
Nicotine, a natural product of various plants including the tobacco plant, is notorious for its addictive properties in tobacco products like cigarettes. But the…
Instead of developing a new drug from the ground up — a time-consuming and costly process — experts say that repurposing medications could accelerate…
Nearly every Alzheimer’s clinical trial has been deemed a failure, yet some participants have positively responded to experimental treatment. Now, scientists are developing predictive…
Acadia Pharmaceuticals said today that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration regarding its supplemental New…
Developing a new drug start to finish can take years — even decades — and cost billions. But, there’s a shortcut: repurposing old drugs…